Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 9, Pages 2426
Publisher
MDPI AG
Online
2021-09-15
DOI
10.3390/cells10092426
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement Has Brains—Do Intracellular Complement and Immunometabolism Cooperate in Tissue Homeostasis and Behavior?
- (2021) Natalia Kunz et al. Frontiers in Immunology
- The Role of PTX3 in Mineralization Processes and Aging-Related Bone Diseases
- (2021) Umberto Tarantino et al. Frontiers in Immunology
- Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy
- (2021) Ugo Giovanni Falagario et al. Cancers
- The Ambivalent Role of miRNAs in Carcinogenesis: Involvement in Renal Cell Carcinoma and Their Clinical Applications
- (2021) Federica Spadaccino et al. Pharmaceuticals
- CD40 Cross-Linking Induces Migration of Renal Tumor Cell through Nuclear Factor of Activated T Cells (NFAT) Activation
- (2021) Paola Pontrelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prostate Cancer Predisposition
- (2021) Yasin Bhanji et al. UROLOGIC CLINICS OF NORTH AMERICA
- The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review
- (2021) Federica Rascio et al. Cancers
- PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma
- (2020) Giuseppe Stefano Netti et al. Aging-US
- Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
- (2020) Rossana Franzin et al. Frontiers in Immunology
- Complement C7 (C7), a Potential Tumor Suppressor, Is an Immune-Related Prognostic Biomarker in Prostate Cancer (PC)
- (2020) Zhao Chen et al. Frontiers in Oncology
- Control of Complement Activation by the Long Pentraxin PTX3: Implications in Age-Related Macular Degeneration
- (2020) Matteo Stravalaci et al. Frontiers in Pharmacology
- LPS-Binding Protein Modulates Acute Renal Fibrosis by Inducing Pericyte-to-Myofibroblast Trans-Differentiation through TLR-4 Signaling
- (2019) Giuseppe Castellano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Tumor cells hijack macrophage-produced complement C1q to promote tumor growth
- (2019) Lubka T. Roumenina et al. Cancer Immunology Research
- Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention
- (2019) Zvi Fishelson et al. Frontiers in Immunology
- The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy
- (2019) Anne Geller et al. Frontiers in Immunology
- The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis
- (2019) Rémi Porte et al. Frontiers in Immunology
- Inflamm-Aging Is Associated with Lower Plasma PTX3 Concentrations and an Impaired Capacity of PBMCs to Express hTERT following LPS Stimulation
- (2019) Aaron L. Slusher et al. MEDIATORS OF INFLAMMATION
- Hallmarks of Cellular Senescence
- (2018) Alejandra Hernandez-Segura et al. TRENDS IN CELL BIOLOGY
- Indications and results of renal biopsy in children: a 36-year experience
- (2018) Luisa Santangelo et al. World Journal of Pediatrics
- Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9
- (2018) Perri Rozenberg et al. Cell Death & Disease
- Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy
- (2018) Terry R. Medler et al. CANCER CELL
- A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement
- (2018) Paolo Giordano et al. PEDIATRIC NEPHROLOGY
- Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2
- (2018) Marco Presta et al. Frontiers in Immunology
- The complement system in cancer: Ambivalence between tumour destruction and promotion
- (2017) Srinivas Mamidi et al. IMMUNOBIOLOGY
- Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
- (2017) Hilary Longhurst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases
- (2017) Matteo Casula et al. VASCULAR PHARMACOLOGY
- Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease
- (2017) Wen-Juan Wang et al. Oncotarget
- Cancer and Aging - the Inflammatory Connection
- (2017) Adar Zinger et al. Aging and Disease
- Context-dependent effects of cellular senescence in cancer development
- (2016) Pacome Lecot et al. BRITISH JOURNAL OF CANCER
- The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
- (2016) Brian K. Kennedy et al. Cell Metabolism
- DNA mismatch repair and the DNA damage response
- (2016) Zhongdao Li et al. DNA REPAIR
- Pentraxins in the activation and regulation of innate immunity
- (2016) Kenji Daigo et al. IMMUNOLOGICAL REVIEWS
- The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+T Cell Responses
- (2016) Jamileh A. Nabizadeh et al. JOURNAL OF IMMUNOLOGY
- Complement in disease: a defence system turning offensive
- (2016) Daniel Ricklin et al. Nature Reviews Nephrology
- Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP
- (2016) P J Paul et al. ONCOGENE
- Complement component 7 (C7), a potential tumor suppressor, is correlated with tumor progression and prognosis
- (2016) Lisha Ying et al. Oncotarget
- Bispecific antibodies in cancer immunotherapy
- (2016) Siqi Chen et al. Human Vaccines & Immunotherapeutics
- High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
- (2016) Wei Xi et al. Scientific Reports
- A Clearer View of the Molecular Complexity of Clear Cell Renal Cell Carcinoma
- (2015) Ian J. Frew et al. Annual Review of Pathology-Mechanisms of Disease
- DNA damage response in cisplatin-induced nephrotoxicity
- (2015) Shiyao Zhu et al. ARCHIVES OF TOXICOLOGY
- PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
- (2015) Eduardo Bonavita et al. CELL
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
- (2015) Remi-Martin Laberge et al. NATURE CELL BIOLOGY
- PTX3 acts as an extrinsic oncosuppressor
- (2015) Eduardo Bonavita et al. Oncotarget
- DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging
- (2015) Fabiola Olivieri et al. Oncotarget
- DDR-mediated crosstalk between DNA-damaged cells and their microenvironment
- (2015) Nicolas Malaquin et al. Frontiers in Genetics
- Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer
- (2014) G. Stallone et al. CANCER RESEARCH
- Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
- (2014) S. K. Vadrevu et al. CANCER RESEARCH
- Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice
- (2014) P Macor et al. LEUKEMIA
- Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
- (2014) Antonio Vavallo et al. MEDICINE
- A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
- (2014) Luisa Santangelo et al. BMC Nephrology
- Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury
- (2013) Giuseppe Stefano Netti et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
- (2013) Tamara Tchkonia et al. JOURNAL OF CLINICAL INVESTIGATION
- Proteolysis of Complement Factors iC3b and C5 by the Serine Protease Prostate-Specific Antigen in Prostatic Fluid and Seminal Plasma
- (2013) M. L. Manning et al. JOURNAL OF IMMUNOLOGY
- The role of complement in mAb-based therapies of cancer
- (2013) Ronald P. Taylor et al. METHODS
- Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab
- (2013) Srinivas Mamidi et al. Molecular Oncology
- A complex secretory program orchestrated by the inflammasome controls paracrine senescence
- (2013) Juan Carlos Acosta et al. NATURE CELL BIOLOGY
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- Antibody Therapeutics in Cancer
- (2013) M. X. Sliwkowski et al. SCIENCE
- Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation
- (2013) Maddalena Gigante et al. BMC Nephrology
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps
- (2012) Kenji Daigo et al. Frontiers in Immunology
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- (2011) Yoshihiro Komohara et al. CANCER SCIENCE
- Novel roles of complement in T effector cell regulation
- (2011) Peter S. Heeger et al. IMMUNOBIOLOGY
- Pathogen Recognition by the Long Pentraxin PTX3
- (2011) Federica Moalli et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Four faces of cellular senescence
- (2011) Francis Rodier et al. JOURNAL OF CELL BIOLOGY
- MAp19, the alternative splice product of the MASP2 gene
- (2011) Søren E. Degn et al. JOURNAL OF IMMUNOLOGICAL METHODS
- M-Ficolin Interacts with the Long Pentraxin PTX3: A Novel Case of Cross-Talk between Soluble Pattern-Recognition Molecules
- (2011) E. Gout et al. JOURNAL OF IMMUNOLOGY
- Enzymatically active prostate-specific antigen promotes growth of human prostate cancers
- (2011) Simon A. Williams et al. PROSTATE
- JAK3 in clear cell renal cell carcinoma: Mutational screening and clinical implications
- (2011) Michela de Martino et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains
- (2010) V. K. Rakyan et al. GENOME RESEARCH
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors
- (2010) Mohd Noor Mohd Hezmee et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- The Long Pentraxin PTX3 Is Crucial for Tissue Inflammation after Intestinal Ischemia and Reperfusion in Mice
- (2009) Danielle G. Souza et al. AMERICAN JOURNAL OF PATHOLOGY
- Resistance to Trastuzumab in Breast Cancer
- (2009) P. R. Pohlmann et al. CLINICAL CANCER RESEARCH
- MAp44, a Human Protein Associated with Pattern Recognition Molecules of the Complement System and Regulating the Lectin Pathway of Complement Activation
- (2009) S. E. Degn et al. JOURNAL OF IMMUNOLOGY
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma
- (2009) Linda Ravenna et al. PROSTATE
- Is complement good or bad for cancer patients? A new perspective on an old dilemma
- (2009) Maciej M. Markiewski et al. TRENDS IN IMMUNOLOGY
- Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: Implications for a novel adjuvant in vaccine design
- (2009) Edward L. Morgan et al. VACCINE
- Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence
- (2008) Juan C. Acosta et al. CELL
- The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity
- (2008) Barbara Bottazzi et al. IMMUNOLOGICAL REVIEWS
- A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells
- (2008) Ganapati V. Hegde et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started